Product Information
PRUCALOPRIDE 2 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.6190 per EA under NDC 72205021930. Its NADAC has been published 60 times since Aug 13, 2025.
FDA first approved this application on Jun 24, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205021930
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PRUCALOPRIDE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA218177FDA Approved
6/24/2025
TE Code
AB
On Market Since
6/24/2025
Pharmacological Classes
Price Statistics
The NADAC for PRUCALOPRIDE 2 MG TABLET has been published 60 times since Aug 13, 2025, and over the history we have for it it has declined 95.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6190 per EA |
|---|---|
| All-time high | $13.6737 (Aug 13, 2025) |
| All-time low | $0.6190 (Sep 23, 2026) |
| 52-week high | $13.1602 |
| 52-week low | $0.6190 |
| Median price | $0.7597 |
| Average price | $2.7961 |
| Largest weekly change | -94.2% (Oct 22, 2025) |
| Weeks tracked | 60 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novadoz Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PRUCALOPRIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-4 Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRUCALOPRIDE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRUCALOPRIDE 2 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $0.6190 per EA (NDC 72205021930), effective Sep 30, 2026.
How has the price of PRUCALOPRIDE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRUCALOPRIDE 2 MG TABLET has declined 95.5%. It has been tracked across 60 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for PRUCALOPRIDE 2 MG TABLET?
Since Aug 13, 2025, the NADAC for PRUCALOPRIDE 2 MG TABLET has ranged from a low of $0.6190 (Sep 23, 2026) to a high of $13.6737 (Aug 13, 2025), with a median of $0.7597 per EA.
Are there cheaper alternatives to PRUCALOPRIDE 2 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRUCALOPRIDE 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PRUCALOPRIDE 2 MG TABLET?
PRUCALOPRIDE 2 MG TABLET (NDC 72205021930) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.